0.00Open0.00Pre Close0 Volume0 Open Interest7.00Strike Price0.00Turnover218.17%IV-84.70%PremiumAug 16, 2024Expiry Date3.21Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7841Delta0.1376Gamma1.11Leverage Ratio-0.0119Theta-0.0033Rho-0.87Eff Leverage0.0029Vega
CureVac Stock Discussion
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
No comment yet